MoneyWorks4Me

Valiant Laboratories informs about disclosure

20 May 2026 Evaluate

Valiant Laboratories has informed that it enclosed disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Valiant Organics.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1744.00
Dr. Reddys Labs. 1226.75
Cipla 1318.80
Lupin 1921.90
Zydus Lifesciences 1132.70
View more..